Skip to main content

James Crowe Jr.

VU researchers ‘goldsmith’ new RSV vaccine approach

Jul. 18, 2013—Vanderbilt vaccine researchers are using gold nanotechnology to develop a new approach to making vaccines.

Read more


Structural snapshot hints at new influenza approach

Feb. 21, 2013—A careful look at how the body’s natural defenses disarm virulent strains of influenza hints at the possibility of a way to fight the flu.

Read more


Targeting post-transplant diabetes

Apr. 12, 2012—Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes.

Read more


On the tail of RSV infection mechanism

Feb. 15, 2012—New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

Read more


Diversity key in antibody repertoire

Oct. 7, 2011—Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.

Read more


Aliquots – VUMC research highlights

Jan. 6, 2011—RSV prefers stressed cells “Stress granules” – globs of proteins and RNAs – form inside cells in response to environmental stressors and are thought to regulate protein production. Several viruses induce stress granule formation, but the function of these structures during virus replication is not well understood. James Crowe Jr., M.D., and colleagues report that...

Read more


VIEW MORE EVENTS >